Forty years of disinfectant failure: Outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride

Clinical Infectious Diseases

Volumn 36, Issue 8, 2003, Pages 954-962

  Tiwari, Tejpratap S P ^a,b,c,e   Ray, Beverly ^b   Jost Jr , Kenneth C ^c   Rathod, Minaxi K ^f   Zhang, Yansheng ^d   Brown Elliott, Barbara A ^d   Hendricks, Kate ^b   Wallace Jr , Richard J ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Bureau of Communicable Diseases   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^e CENTERS FOR DIS CONTR AND PREV   (United States)

^f MS E 61 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; DETERGEX; DETERGICIDE; DISINFECTANT AGENT; STEROID; BENZALKONIUM;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; DISINFECTION; DRUG CONTAMINATION; EPIDEMIC; FEMALE; HUMAN; HUMAN TISSUE; INFECTIOUS ARTHRITIS; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; STEROID THERAPY; SYNOVIAL FLUID; UNITED STATES; ISOLATION AND PURIFICATION; MIDDLE AGED; MYCOBACTERIUM;

ADULT; AGED; AGED, 80 AND OVER; BENZALKONIUM COMPOUNDS; DISEASE OUTBREAKS; DRUG CONTAMINATION; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TEXAS;

EID: 0037445547     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/368192     Document Type: Article

References (44)

1. Sanford JP. Disinfectants that don't [editorial]. Ann Intern Med 1970; 72:282-3.
2. Plotkin SA, Austrian R. Bacteremia caused by Pseudomonas sp. following the use of materials stored in solutions of a cationic surface-active agent. Am J Med Sci 1958; 235:621-7.
3. Failure of disinfectants to disinfect [editorial]. Lancet 1958; 2:306.
4. Malizia WF, Gangarosa EJ, Goley AF. Benzalkonium chloride as a source of infection. N Engl J Med 1960; 263:800-2.
5. Lee JC, Fialkow PJ. Benzalkonium chloride - source of hospital infection with gram-negative bacteria. JAMA 1961; 177:144-6.
6. Centers for Disease Control. Food and Drug Administration warning - contaminated detergent solution. MMWR Morb Mortal Wkly Rep 1969; 18:366.
7. Kaslow RA, Mackel DC, Mallison GF. Nosocomial pseudobacteremia: positive blood cultures due to contaminated benzalkonium antiseptic. JAMA 1976; 236:2407-9.
8. Frank MJ, Schaffner W. Contaminated aqueous benzalkonium chloride: an unnecessary hospital infection hazard. JAMA 1976; 236:2418-9.
9. Wishart MM, Riley TV. Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant. Med J Aust 1976; 2:710-2.
10. Dixon RE, Kaslow RA, Mackel DC, Fulkerson CC, Mallison GF. Aqueous quaternary ammonium antiseptics and disinfectants [editorial]. JAMA 1976; 236:2415-7.
11. Ehrenkranz NJ, Bolyard EA, Wiener M. Antibiotic-sensitive Serratia marcescens infections complicating cardiopulmonary operations: contaminated disinfectant as a reservoir. Lancet 1980; 2:1289-92.
12. Fox JG, Beaucage CM, Folta CA, Thorton GW. Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzalkonium chloride. J Clin Microbiol 1981; 14:157-60.
13. Nakashima AK, McCarthy MA, Martone WJ, Anderson RL. Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. J Clin Microbiol 1987; 25:1014-8.
14. Sautter RL, Mattman LH, Legaspi RC. Serratia marcescens meningitis associated with a contaminated benzalkonium chloride solution. Infection Control 1984; 5:223-5.
15. Olson RK, Voorhees RE, Eitzen HE, Rolka H, Sewell CM. Cluster of post-injection abscesses related to corticosteroid injections and use of benzalkonium chloride. West J Med 1999; 170:143-7.
16. Georgia Division of Public Health. Abscesses in an allergy practice due to Mycobacterium chelonae. Georgia Epidemiol Rep 1990; 6:2.
17. Donowithz LG. Benzalkonium chloride is still in use. Infect Control Hosp Epidemiol 1991; 12:186-7.
18. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1985.
19. Jost KC Jr, Dunbar DF, Barth SS, Headley VL, Elliot BL. Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven recognition models. J Clin Microbiol 1995; 33:1270-7.
20. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31:175-8.
21. Steingrube VA, Gibson JL, Brown BA, et al. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol 1995; 33:149-53.
22. Wallace RJ Jr, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol 1993; 31:2697-701.
23. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
24. Zhang Y, Rajagopalan M, Brown BA, Wallace RJ Jr. Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J Clin Microbiol 1997; 35:3132-9.
25. Villaneuva A, Calderon RV, Vargas BA, et al. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis 1997; 24:1147-53.
26. Kauppinen J, Mäntyjaärvi R, Katila M-L. Random amplified polymorphic DNA genotyping of Mycobacterium malmoense. J Clin Microbiol 1994; 32:1827-9.
27. Linton CJ, Jalal H, Leeming JP, Millar MR. Rapid discrimination of Mycobacterium tuberculosis strains by random amplified polymorphic DNA analysis. J Clin Microbiol 1994; 32:2169-74.
28. Robison RA, Bodily HL, Robinson DF, Christensen RP. Suspension method to determine reuse life of chemical disinfectants during clinical use. Appl Environ Microbiol 1988; 54:158-64.
29. Russell AD. Activity of biocides against mycobacteria. Soc Appl Bacteriol Symp Ser 1996; 25:87S-101S.
30. Rikimaru T, Kondo M, Kondo S, Oizumi K. Efficacy of common an-tiseptics against mycobacteria. Int J Tuberc Lung Dis 2000; 4:570-6.
31. Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 1978; 36:839-46.
32. Beck A. Mycobacterium fortuitum in abscesses of man. J Clin Pathol 1965; 8:307-13.
33. Borghans JGA, Stanford JL. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 1973; 107:1-8.
34. Camargo D, Saad C, Ruiz F, et al. Iatrogenic outbreak of M. chelonae skin abscesses. Epidemiol Infect 1996; 117:113-9.
35. Canilang B, Armstrong D. Subcutaneous abscesses due to Mycobacterium fortuitum. Am Rev Resp Dis 1968; 97:451-4.
36. Galil K, Miller LA, Yakrus MA, et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis 1999; 5:681-7.
37. Gremillion DH, Mursch SB, Lerner CJ. Injection site abscesses caused by Mycobacterium chelonei. Infection Control 1983; 4:25-8.
38. Inman PM, Beck A, Brown AE, Stanford JL. Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol 1969; 100:141-7.
39. Owen M, Smith A, Coultras J. Granulomatous lesions occurring at site of injections of vaccines and antibiotics. South Med J 1963; 56:949-52.
40. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987; 317:197-201.
41. Torres JR, Rios-Fabra A, Murillo J, Montecinos E, Caceres AM. Injection site abscess due to the Mycobacterium fortuitum-chelonae complex in the immunocompetent host. Infect Dis Clin Prac 1998; 7:56-60.
42. Vandepitte J, Desmyter J, Brochier J, Gatti F. Une nouvelle affection mycobactéries: l'abcès postinjection à M. fortuitum. Ann Soc Belge Méd Trop 1962; 4:555-60.
43. Wenger JD, Spika JS, Smithwick RW, et al. Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. JAMA 1990; 264:373-6.
44. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 1998; 52:453-90.